Cite this: Technology Insight: The Evolution of Tissue-Engineered Vascular Grafts--From Research to Clinical Practice - Medscape - Jul 01, 2007. The recent transition to clinical use by two ...

The HEMASHIELD grafts are the most used, most studied vascular products available in the market today. More than 2 million HEMASHIELD grafts have been implanted worldwide, demonstrating clinical ...

LifeSpan ePTFE Vascular Grafts for peripheral vascular reconstructions and AV Access have been used in clinical practice for more than 15 years. It features soft ePTFE material with superb suture ...

A new type of bioengineered blood vessel showed strong results in treating severe vascular injuries, potentially offering ...

The first acellular tissue engineered vessel for adults with vascular trauma in a bodily extremity has been approved by the U.S. FDA. Symvess, which comes from regenerative tissue developer Humacyte ...

Gore & Associates announced the recent CE Mark approval of a lower-profile Gore Viabahn VBX balloon expandable endoprosthes ...

Doctors at St. Barbara's Hospital in Sosnowiec, in Poland's southern Silesia region, say they have successfully used bovine ...

SYMVESS is a bioengineered human tissue designed as a vascular conduit for arterial replacement in adults facing imminent limb loss. How does SYMVESS compare to traditional vein grafts?